MFN2 and amyotrophic lateral sclerosis: A novel and exciting role of MFN2 at neuromuscular synaptic junctions (NMJs), which decline in aging-related sarcopenia as well as in ALS-related skeletal muscle wasting, has been elucidated by Wang and colleagues (Wang et al., 2018a).